Scrip Neurology

LSI Panel Says Women’s Health Breaks Out Of ‘Bikini Box’ As New Business Models Catch Investors’ Eye

Marion Webb — Fri, 03 Apr 2026 22:36:03 +0000

For years, women’s health has been narrowly defined as fertility, pregnancy and a handful of screening tools. At the LSI USA conference in Dana Point, CA, a panel of women’s health company leaders and

No Evidence Of Benefit: Two Trials Prompt Calls to End Routine Use Of J&J’s Impella Heart Pump

Shubham Singh — Fri, 03 Apr 2026 17:08:17 +0000

The clinical evidence base for Johnson & Johnson’s Impella miniaturized heart pumps has been called into question by two randomized trials presented at the American College of Cardiology’s annual

Menopause, Heart Disease, Alzheimer’s Are All Part Of Women’s Health, Industry Leaders Say

Marion Webb — Tue, 31 Mar 2026 23:19:58 +0000

Women’s health investment is increasingly framed as one of the largest untapped opportunities and is expected to reach more than $600bn by 2030, according to PwC. Yet the lion’s share of funding conti

Boston Scientific Eyes Expanded Watchman Indication After CHAMPION-AF Results; Analysts Flag Caveats

Shubham Singh — Tue, 31 Mar 2026 19:09:43 +0000

The CHAMPION-AF trial has delivered the data Boston Scientific needed to pursue a broader indication for its Watchman FLX left atrial appendage closure device. Presented at the American College of C

HeartBeam Teams Up With Mount Sinai To Bring Clinical-Grade Cardiac Monitoring Into The Home

Brian Bossetta — Fri, 27 Mar 2026 14:14:11 +0000

One of the nation’s top heart hospitals and a leading medtech firm specializing in cardiac monitoring are joining forces to build AI-ECG models to better manage and potentially prevent heart disease.

LSI Panel: Investors, Medtech Leaders Expect M&A Rebound In 2026, But Only For Strong Assets

Marion Webb — Thu, 26 Mar 2026 18:02:02 +0000

After a sluggish period, marked by macroeconomic uncertainty, geopolitical instability and a largely closed IPO window, medtech executives are cautiously optimistic that dealmaking will pick up in 202

Medtronic Expands OmniaSecure Approval to Left Bundle Branch Pacing, Raising Competitive Stakes

Shubham Singh — Wed, 25 Mar 2026 15:54:06 +0000

Medtronic’s expanded FDA approval of the OmniaSecure cardiac defibrillation lead for left bundle branch area pacing (LBBAP) gives the company an integrated pacing-and-defibrillation option in a part o

JenaValve’s Trilogy Becomes First FDA-Approved TAVR Treatment For Aortic Regurgitation

Elizabeth Orr — Wed, 18 Mar 2026 18:54:27 +0000

The US Food and Drug Administration has approved JenaValve’s Trilogy HeartValve system for patients with symptomatic, severe aortic regurgitation who are at high risk for surgical valve replacement, m

Not Losing Heart: HeartBeam Wins FDA Approval Of Novel ECG Device After Appealing NSE Determination

Brian Bossetta — Mon, 09 Mar 2026 19:49:31 +0000

When the US Food and Drug Administration failed to clear at 510(k) for HeartBeam’s novel ECG device, the company didn’t lose faith. “We stood behind our clinical data,” HeartBeam CEO Robert Eno told

Stakeholders Ask CMS For Additional TAVR Indications

Mark McCarty — Mon, 02 Mar 2026 21:17:02 +0000

The Centers for Medicare & Medicaid Services has reopened the coverage memo for transcatheter aortic valve replacement (TAVR) devices to consider coverage for asymptomatic aortic stenosis (AS).

Serious Injuries Linked To Abiomed Impella Heart Pump Component

Brian Bossetta — Fri, 27 Feb 2026 18:26:38 +0000

The US Food and Drug Administration reports four serious injuries associated with purge leaks from certain Abiomed Impella Generation 1 Purge Cassettes, which are used with Impella heart pumps. Thou

Esperto Medical Bets On Physics, Not ML, For Accurate, Cuffless Blood Pressure Monitoring

Marion Webb — Fri, 20 Feb 2026 22:27:00 +0000

Esperto Medical hopes to crack the code for continuous, noninvasive, calibration-free, and most of all, truly accurate blood pressure monitoring with an acoustic approach that analyzes arterial shape

NASA’s Former AI Chief Omar Hatamleh: AGI Is Closer Than We Think, Then Everything Will Change

Marion Webb — Mon, 16 Feb 2026 18:00:00 +0000

After nearly three decades at NASA, most recently as chief artificial intelligence officer at NASA Goodard Flight Center in Maryland, Omar Hatamleh is pondering the next chapter in his life and writin

Edwards To Launch Surgical LAAC In 2026 As Structural Heart Expansion Accelerates

Shubham Singh — Mon, 16 Feb 2026 15:26:42 +0000

Edwards Lifesciences said it plans to launch a new surgical left atrial appendage closure (LAAC) technology later this year, a move expected to support growth in its surgical business. The surgical se

FDA Holds ‘Refresher’ Town Hall On Low-Risk, General Wellness Medical Devices

Brian Bossetta — Thu, 12 Feb 2026 21:17:02 +0000

The US Food and Drug Administration wants to reduce the regulatory burden on low-risk technologies, according to Henry Roberts, digital health specialist at the agency’s Office of Strategic Partnershi

Medtronic To Acquire Cathworks For $585M, Expanding Its Cardiology Portfolio

Marion Webb — Wed, 04 Feb 2026 14:19:48 +0000

After years of collaboration, Medtronic has exercised its option to acquire Cathworks for up to $585m, strengthening its position in the wire-free coronary physiology assessment. Medtronic has held a

Multiple Injuries Associated With Early Alert For Certain Abiomed Impella Heart Pumps

Brian Bossetta — Tue, 03 Feb 2026 19:42:34 +0000

Abiomed has updated the instructions for use for its Impella RP with SmartAssist and Impella RP Flex with SmartAssist after reports of serious injuries. In an early alert posted today, the US FDA sa

Hey Doc, What’s That Sound? FDA Clearance Broadens Scope Of AI Heart Murmur Detection Platform

Brian Bossetta — Thu, 29 Jan 2026 17:24:05 +0000

For more than 200 years doctors have used stethoscopes to diagnose patients. Though they have changed considerably over time, especially with the introduction of the first digital stethoscope in the l

FDA Offers Premarket Submission Recommendations For Makers Of Cuffless BP Devices

Brian Bossetta — Tue, 27 Jan 2026 22:15:23 +0000

Manufacturers of cuffless blood pressure monitors should describe the intended use, technology, and principles of operation in their premarket submissions to the Food and Drug Administration, accordin

Abbott Looks To IVDs Future With Exact Sciences And Underscores PFA Potential

Ashley Yeo — Thu, 22 Jan 2026 22:35:27 +0000

Abbott climbed back above the $30bn revenues threshold for its combined devices and in vitro diagnostics portfolios in 2025, with its devices scoring 12.6% growth to $21,387m. Diagnostics declined by